Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $0.03.

  • Nephros' EPS (Basic) rose 5000.0% to $0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.14, marking a year-over-year increase of 25555.56%. This contributed to the annual value of $0.01 for FY2024, which is 10468.72% up from last year.
  • As of Q3 2025, Nephros' EPS (Basic) stood at $0.03, which was up 5000.0% from $0.02 recorded in Q2 2025.
  • In the past 5 years, Nephros' EPS (Basic) ranged from a high of $0.05 in Q1 2025 and a low of -$0.31 during Q3 2022
  • For the 5-year period, Nephros' EPS (Basic) averaged around -$0.06, with its median value being -$0.04 (2023).
  • Its EPS (Basic) has fluctuated over the past 5 years, first crashed by 23333.33% in 2022, then skyrocketed by 35000.0% in 2025.
  • Quarter analysis of 5 years shows Nephros' EPS (Basic) stood at -$0.11 in 2021, then grew by 9.09% to -$0.1 in 2022, then surged by 40.0% to -$0.06 in 2023, then surged by 157.64% to $0.03 in 2024, then dropped by 13.25% to $0.03 in 2025.
  • Its EPS (Basic) was $0.03 in Q3 2025, compared to $0.02 in Q2 2025 and $0.05 in Q1 2025.